95 related articles for article (PubMed ID: 25711058)
1. [Evoked retinal and cortical potentials in children with advanced and resistant retinoblastoma after neoadjuvant polychemotherapy and superselective intra-arterial chemotherapy].
Zueva MV; Tsapenko IV; Saakian SV; Panteleeva OG; Zharua AA; Orlovskaia LS
Vestn Oftalmol; 2014; 130(5):22-9. PubMed ID: 25711058
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiological evaluation of retinal function after systemic and superselective intra-arterial chemotherapy for retinoblastoma].
Zueva MV; Saakyan SV; Zueva MV; Saakyan SV
Vestn Oftalmol; 2015; 131(5):111-114. PubMed ID: 26845881
[TBL] [Abstract][Full Text] [Related]
3. Non-selectivity of ERG reductions in eyes treated for retinoblastoma.
Liu CY; Jonna G; Francis JH; Marr BP; Abramson DH; Brodie SE
Doc Ophthalmol; 2014 Feb; 128(1):13-23. PubMed ID: 24213436
[TBL] [Abstract][Full Text] [Related]
4. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
5. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Arch Ophthalmol; 2010 Mar; 128(3):370-2. PubMed ID: 20212212
[No Abstract] [Full Text] [Related]
6. Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram.
Liasis A; Paez-Escamilla M; Gruszewski J; Singh AD; Nischal KK
Ophthalmic Genet; 2023 Aug; 44(4):385-388. PubMed ID: 36330605
[TBL] [Abstract][Full Text] [Related]
7. Retinal function and corresponding pathology in advanced retinoblastoma.
Weiss AH; Kelly JP; Kapur RP; Pendergrass T
Arch Ophthalmol; 2008 Nov; 126(11):1507-12. PubMed ID: 19001217
[TBL] [Abstract][Full Text] [Related]
8. ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma.
Brodie SE; Paulus YM; Patel M; Gobin YP; Dunkel IJ; Marr BP; Abramson DH
Br J Ophthalmol; 2012 Jun; 96(6):877-80. PubMed ID: 22426950
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of retinoblastoma following intra-arterial chemotherapy.
Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
12. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
13. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.
Hadjistilianou T; Coriolani G; Bracco S; Gennari P; Caini M; Cerase A; Galimberti D; De Francesco S; De Luca M; Mastrangelo D
J Pediatr Ophthalmol Strabismus; 2014; 51(1):32-8. PubMed ID: 24308859
[TBL] [Abstract][Full Text] [Related]
15. Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function.
Abdelhakim AH; Francis JH; Marr BP; Gobin YP; Abramson DH; Brodie SE
Br J Ophthalmol; 2017 May; 101(5):623-628. PubMed ID: 27539090
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial and oral digoxin therapy for retinoblastoma.
Patel M; Paulus YM; Gobin YP; Djaballah H; Marr B; Dunkel IJ; Brodie S; Antczak C; Folberg R; Abramson DH
Ophthalmic Genet; 2011 Sep; 32(3):147-50. PubMed ID: 21446853
[TBL] [Abstract][Full Text] [Related]
17. Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma.
Lubiński W; Zajaczek S; Sych Z; Penkala K; Palacz O; Lubiński J
Ophthalmic Genet; 2002 Jun; 23(2):99-107. PubMed ID: 12187428
[TBL] [Abstract][Full Text] [Related]
18. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
20. Silicone oil insulation effects on flash electroretinogram and visual evoked potential in patients with retinal detachment.
Papachristou A; Lambraki A; Giannakopoulou T; Tsilimbaris MK; Plainis S
J Optom; 2024; 17(2):100502. PubMed ID: 37931571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
